MoneyWorks4Me

Senores Pharmaceutic - Quaterly Results

23 Jul 2025 Evaluate
The total revenue for the June 2025 quarter zoomed 164.97% to Rs. 198.20 millions as compared to Rs. 74.80 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 770.97% to Rs. 27.00  millions  from Rs. 3.10 millions in previous same quarter.Operating Profit saw a handsome growth to 72.30 millions from 16.70 millions in the quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 198.20 74.80 164.97 198.20 74.80 164.97 385.40 340.10 13.32
Other Income 83.90 24.50 242.45 83.90 24.50 242.45 219.90 68.40 221.49
PBIDT 72.30 16.70 332.93 72.30 16.70 332.93 147.10 67.80 116.96
Interest 17.60 8.00 120.00 17.60 8.00 120.00 65.20 27.10 140.59
PBDT 54.70 8.70 528.74 54.70 8.70 528.74 81.90 40.70 101.23
Depreciation 18.80 5.20 261.54 18.80 5.20 261.54 30.80 20.40 50.98
PBT 35.90 3.50 925.71 35.90 3.50 925.71 51.10 20.30 151.72
TAX 8.90 0.40 2125.00 8.90 0.40 2125.00 14.20 12.20 16.39
Deferred Tax 5.10 -2.30 -321.74 5.10 -2.30 -321.74 -0.30 -1.40 -78.57
PAT 27.00 3.10 770.97 27.00 3.10 770.97 36.90 8.10 355.56
Equity 460.54 332.66 38.44 460.54 332.66 38.44 460.40 305.10 50.90
PBIDTM(%) 36.48 22.33 63.39 36.48 22.33 63.39 38.17 19.94 91.46
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..